Gaush Meditech Balance Sheet Health

Financial Health criteria checks 5/6

Gaush Meditech has a total shareholder equity of CN¥1.7B and total debt of CN¥618.6M, which brings its debt-to-equity ratio to 36.5%. Its total assets and total liabilities are CN¥2.8B and CN¥1.1B respectively. Gaush Meditech's EBIT is CN¥253.3M making its interest coverage ratio 5.8. It has cash and short-term investments of CN¥833.0M.

Key information

36.5%

Debt to equity ratio

CN¥618.56m

Debt

Interest coverage ratio5.8x
CashCN¥832.97m
EquityCN¥1.70b
Total liabilitiesCN¥1.15b
Total assetsCN¥2.84b

Recent financial health updates

No updates

Recent updates

Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive

Apr 05
Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive

Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

Dec 07
Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Aug 08
A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

Jun 01
Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

Financial Position Analysis

Short Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥891.7M).

Long Term Liabilities: 2407's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥255.1M).


Debt to Equity History and Analysis

Debt Level: 2407 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if 2407's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 2407's debt is well covered by operating cash flow (43.7%).

Interest Coverage: 2407's interest payments on its debt are well covered by EBIT (5.8x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.